2022 American Transplant Congress
A Novel National Program to Maximize Utilization of Lung and Heart Allografts from Donors After Brain Death (DBD) and Donors After Circulatory Death (DCD) for Transplantation
*Purpose: To build a national network of dedicated cardiothoracic surgical procurement and Organ Care System (OCS™) ex-vivo perfusion clinical experts to: Maximize cardiothoracic donor organ…2022 American Transplant Congress
Combined Heart-Liver Transplantation for Failing Fontan Physiology: A Large Single Center Comparative Analysis
*Purpose: The rate of combined heart-liver transplantation (HLT) has tripled in the last decade, and continues to rise along with the number of patients with…2022 American Transplant Congress
Clinical Use of the SIPAT Score in a Large Heart Transplant Program
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: The Stanford Integrated Psycosocial Assessment for Transplant (SIPAT) score predicts outcome after heart transplantation (HTx). Compliance with medications and clinic visits are important leading…2022 American Transplant Congress
Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology
*Purpose: Fontan-associated liver disease (FALD) is a well-described complication of Fontan physiology. More patients with failing Fontan are being evaluated for heart transplant and evidence-based…2021 American Transplant Congress
Allograft Discard Risk Index for Heart Transplantation
*Purpose: The number of patients awaiting heart transplantation (HTx) substantially exceeds the number of donor hearts transplanted each year, yet nearly 70% of consented donor…2021 American Transplant Congress
Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis
Baylor University Medical Center, Dallas, TX
*Purpose: Post-transplant care is multifaceted with protocols to provide oversight and maintain the standard of care. While institutional protocols for post-transplant HLA antibody surveillance after…2021 American Transplant Congress
Liver Biopsy as a Predictor in Risk Stratification for Heart Transplant Candidates
*Purpose: Patients undergoing workup for Orthotopic Heart Transplant (OHT) undergo multi-organ evaluation for risk stratification. While cirrhosis is a known predictor of poor outcomes in…2021 American Transplant Congress
Impact of a Pharmacist in an Outpatient Heart Transplant Clinic
1UNC Health Care, Chapel Hill, NC, 2Eshelman School of Pharmacy, Chapel Hill, NC
*Purpose: Data describing the impact of a pharmacist in ambulatory medication management of heart transplant recipients (HTRs) is lacking. Following the addition of an ambulatory…2021 American Transplant Congress
Significance of Repeated 1r Rejections in Heart Transplantation
1Yale New Haven Hospital, New Haven, CT, 2Yale University School of Medicine, New Haven, CT
*Purpose: 1R rejection is commonly seen in routine post-transplant biopsies. While presence of occasional 1R rejection is not considered to be detrimental, the significance of…2021 American Transplant Congress
Combined Heart-liver Transplantation in Patients with Familial Amyloidosis – Analysis of Optn/Unos Database
Virginia Commonwealth University, Richmond, VA
*Purpose: We compared the outcomes after combined heart-liver transplant (CHLT) for patients with Familial Amyloidosis (FA) versus other indications (primary cardiac:congenital heart disease and idiopathic…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 30
- Next Page »